Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome
暂无分享,去创建一个
K. Nakanishi | N. Yoshikawa | A. Tanaka | K. Nozu | K. Iijima | Tomohiko Yamamura | Tomoko Horinouchi | Yuya Aoto | Shinya Ishiko | Atsushi Kondo | A. Takeda | H. Hayashi | T. Ninchoji | Yuko Shima | Nana Sakakibara | Sadayuki Nagai | T. Ueno | M. Koizumi | C. Nagano | S. Ishiko | Naoto Hamano | Masayuki Hara | T. Horinouchi | Y. Aoto | M. Hara
[1] H. Nagaraja,et al. Immunostaining for galactose-deficient immunoglobulin A is not specific for primary immunoglobulin A nephropathy. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] K. Nakanishi,et al. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases , 2020, Scientific Reports.
[3] Yu Liu,et al. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy. , 2020, Clinical immunology.
[4] G. Cavalleri,et al. An Exome Sequencing Study of 10 Families with IgA Nephropathy , 2019, Nephron.
[5] Hong Zhang,et al. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy , 2019, Kidney international reports.
[6] K. Nakanishi,et al. Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome , 2019, Molecular genetics & genomic medicine.
[7] Yusuke Suzuki,et al. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1 , 2018, Monoclonal antibodies in immunodiagnosis and immunotherapy.
[8] K. Nakanishi,et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome , 2018, Clinical and Experimental Nephrology.
[9] Jie Ding,et al. Expert consensus guidelines for the genetic diagnosis of Alport syndrome , 2018, Pediatric nephrology (Berlin, West).
[10] Yusuke Suzuki,et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. , 2018, Kidney international.
[11] K. Nakanishi,et al. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[12] Yusuke Suzuki,et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] N. Yamanaka,et al. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for α5(IV) and α2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy , 2015, Clinical and Experimental Nephrology.
[14] K. Nakanishi,et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. , 2014, Kidney international.
[15] I. Vořechovský,et al. Natural history of genetically proven autosomal recessive Alport syndrome , 2014, Pediatric Nephrology.
[16] C. Zeng,et al. Challenge in pathologic diagnosis of Alport syndrome: evidence from correction of previous misdiagnosis , 2012, Orphanet Journal of Rare Diseases.
[17] B. Julian,et al. The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[18] Y. Yamaguchi,et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. , 2003, Kidney international.
[19] K. Nitta,et al. Glomerular Expression of α2(IV) and α5(IV) Chains of Type IV Collagen in Patients with IgA Nephropathy , 2002, Nephron.
[20] C. Kashtan. Alport syndrome and thin glomerular basement membrane disease. , 1998, Journal of the American Society of Nephrology : JASN.
[21] H. Sakaguchi,et al. A quantitative study of glomerular basement membrane changes in IgA nephropathy , 1988, The Journal of pathology.
[22] N. Yoshikawa,et al. Lysis of the glomerular basement membrane in children with IgA nephropathy and Henoch‐Shönlein nephritis , 1986, The Journal of pathology.
[23] V. Gutierrez-Millet,et al. IgA nephropathy: an ultrastructural study. , 1981, Ultrastructural pathology.
[24] K. Nitta,et al. Glomerular expression of alpha2(IV) and alpha5(IV) chains of type IV collagen in patients with IgA nephropathy. , 2002, Nephron.
[25] E. Grundmann,et al. Ultrastructural changes of glomerular basement membrane in IgA nephritis: relationship to hematuria. , 1988, Ultrastructural pathology.
[26] K. Chan,et al. PERIPHERAL GLOMERULAR CAPILLARY WALL LESIONS IN IGA NEPHROPATHY AND THEIR IMPLICATIONS , 1984, Pathology.